Search results for " Transfusion"

showing 10 items of 148 documents

Clinical presentation and outcome of 20 fetuses with parvovirus B19 infection complicated by severe anemia and/or fetal hydrops

2014

Aim The aim of this study was to assess the prognosis of parvovirus B19 infection with severely anemic and/or hydropic fetuses according to initial ultrasound and biological criteria. Material and methods Retrospective study of 20 cases of congenital parvovirus B19-proven infection (positive PCR) complicated by fetal anemia and/or hydrops was examined. Anemia was suspected on an elevated peak systolic velocity of the middle cerebral artery and was confirmed by fetal blood sampling. Results Survival rate was 70% (14/20) overall and 76% (13/17) for fetuses with one or more transfusions. When fetal effusion regressed after the transfusion, all 11 fetuses survived, and neonatal condition was fa…

medicine.medical_specialtyBlood transfusionbiologyPleural effusionParvovirusObstetricsAnemiabusiness.industrymedicine.medical_treatmentObstetrics and GynecologyGestational agemedicine.diseasebiology.organism_classificationMirror syndromeSurgeryEffusionmedicinebusinessSurvival rateGenetics (clinical)Prenatal Diagnosis
researchProduct

Epidemiología de la transfusión sanguínea en los Servicios de Medicina Intensiva en España: «Transfusion Day»

2022

Objective To describe the transfusion practice in the ICUs in Spain, according to national and international recommendations (guidelines).DesignProspective, cross-sectional, multi-centre study.ScopeData collection was carried out by means of a questionnaire sent electronically to the Heads of Service of 111 ICUs in Spain.Participants1,448 patients were included, aged 61.8 (SD 15.7) years, 66.2% male, with an SOFA of 4.7 ± 3.8 and average stay of 10.62 ± 17.49 days.VariablesDemographic and clinical variables of the patients were collected, as well as variables related to the transfusion act.ResultsOf the 1,448 patients, 9.9% received al least one transfusion of any blood product, 3.7% fresh …

medicine.medical_specialtyBlood transfusionbusiness.industryAnemiamedicine.medical_treatmentHemodynamics030208 emergency & critical care medicineCritical Care and Intensive Care Medicinemedicine.disease03 medical and health sciencesRed blood cell0302 clinical medicinemedicine.anatomical_structure030228 respiratory systemBlood productInternal medicineEpidemiologyMedicinePlateletHemoglobinbusinessMedicina Intensiva
researchProduct

Transfusion Need at Diagnosis or Its Development During the First Year of Diagnosis in Primary Myelofibrosis: Effect On Survival and Correlation with…

2009

Abstract Abstract 1909 Poster Board I-932 Background: The International Prognostic Scoring System (IPSS) for primary myelofibrosis (PMF) utilizes five independent predictors of inferior survival; of these, a hemoglobin level <10 g/dL has the highest impact on survival (Cervantes et al. Blood 2009;113:2895). In the current study, we examined the additional prognostic impact of transfusion need at diagnosis or becoming transfusion-dependent in the first year of diagnosis. These events were also correlated with JAK2 or TET2 mutational status. Methods: Patients were selected from the Mayo Clinic PMF database based on availability of bone marrow histology and IPSS-relevant information at diag…

medicine.medical_specialtyBlood transfusionbusiness.industryProportional hazards modelmedicine.medical_treatmentImmunologymyelofibrosisTransfusion HistoryCell BiologyHematologyBiochemistrySettore MED/15 - Malattie Del SangueSurgeryTransplantationLog-rank testInternational Prognostic Scoring SystemInternal medicineCohortmedicinebusinessSurvival analysisBlood
researchProduct

Nasal packing in posterior epistaxis. Comparison of two methods

2010

Objective: To evaluate tolerance and efficiency of two nasal blocking systems for posterior refractory epistaxis. Patients and methods: A five year comparative and longitudinal prospective study was developed in patients with epistaxis who attended our Emergency Unit and who required posterior nasal packing. Two groups were considered: one group was treated with a bi-chamber pneumatic inflation system (n=105). In the other one, posterior occlusion was carried out with gauze, accessing through the mouth and using nasal reinforcement (n=47). The tolerance was measured by means of an analogue scale of pain intensity during the placement and maintenance of the packing, as well as for the need o…

medicine.medical_specialtyBlood transfusionbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)General MedicineBalloonNasal packingSurgeryRefractoryConcomitantMedicinePosterior epistaxisbusinessProspective cohort studyActa Otorrinolaringologica (English Edition)
researchProduct

Is cell salvage safe in liver resection? A pilot study

2007

Abstract Study Objective To investigate the quality of cell salvaged (CS) blood in patients undergoing hemihepatectomy (study group) and compare it with CS-blood from aortic surgery (control group). Design Observational study. Setting Operating room in a university hospital. Measurements 6 patients undergoing hemihepatectomy or aortobifemoral bypass with intraoperative blood loss of more than 800 mL. Samples were drawn from the central venous catheter, from the reservoir of a CS recovery system, and from the processed blood in each patient to determine interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor (TNF), complement C3a, and the terminal complement complex C5b-9. Microbiological ana…

medicine.medical_specialtyBlood transfusionmedicine.medical_treatmentCellPilot ProjectsComplement Membrane Attack ComplexResectionBlood Transfusion AutologousmedicineHepatectomyHumansInterleukin-6business.industryInterleukin-8InterleukinBacterial InfectionsInterleukin-10Complement systemSurgeryAnesthesiology and Pain Medicinemedicine.anatomical_structureCytokineComplement C3aErythrocyte TransfusionbusinessAnaerobic exerciseCentral venous catheterJournal of Clinical Anesthesia
researchProduct

Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas?

2014

Summary Leishmaniasis clinical spectrum ranges from cryptic infection to fatal visceral leishmaniasis. Cryptic infection can be found in blood donors from areas endemic for leishmaniasis all over the world. Although leishmaniasis is a classic vector-borne disease, cases of transfusion transmitted leishmaniasis have been reported especially in nonendemic areas. Most of these cases regarded infants or children. This paper reviews the literature on this specific feature and the impact of leishmaniasis on transfusion medicine. Relevant literature was found through PubMed. The reference lists of selected articles identified further sources. Conclusions: Blood donations by emigrants or travelers f…

medicine.medical_specialtyLeishmaniasiSettore MED/09 - Medicina InternaBlood DonorsDiseaseBlood donationsmedicineAnimalsHumansTravel medicineBlood TransfusionIntensive care medicineLeishmaniabiologyTransfusion Medicinebusiness.industryPublic Health Environmental and Occupational HealthTransfusion medicineLeishmaniasismedicine.diseaseLeishmaniabiology.organism_classificationtransfusion blood donorCryptic infectionBloodInfectious DiseasesVisceral leishmaniasisLeishmaniasis; transfusion blood donors;ImmunologyLeishmaniasis Visceralbusiness
researchProduct

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

2013

Substantial improvements in the safety of blood and plasma products for the management of bleeding disorders have been achieved in recent decades. This has led some clinicians to believe that the infectious threat is over and that inhibitor formation is the foremost complication of hemophilia therapy. On the contrary, elimination of all microbes from blood is difficult, potentially impossible, and there are always threats from emerging pathogens. The risk of infection transmission is also increasing due to greater exposure to products, increasing prophylaxis and high-dose regimens for immune tolerance, and longevity of hemophilia patients. Current products can be considered "reasonably safe…

medicine.medical_specialtyLong term treatmentContext (language use)Hemophilia AInfectionsEmerging infectionsSAFERHumans; Blood Coagulation Disorders; Hemophilia A; Blood Transfusion; InfectionmedicineHumansBlood TransfusionIntensive care medicinePathogenTransmission (medicine)business.industryRisk of infectionTransfusion ReactionHematologyBlood Coagulation Disordersmedicine.diseaseSettore MED/07 - Microbiologia e Microbiologia ClinicaThrombosisSurgeryHemostasisPlasma productsBlood safetyCardiology and Cardiovascular MedicinebusinessInfectionSeminars in thrombosis and hemostasis
researchProduct

Harnessing HLA‐E‐restricted CD8 T lymphocytes for adoptive cell therapy of patients with severe COVID‐19

2020

SARS-CoV-2 is spreading worldwide, and is a pandemic virus that has infected almost 5 million individuals and causing 300.000 deaths, as of mid-May 2020. Because SARS-CoV-2 is a new virus in humans there are currently no vaccines, monoclonal antibodies (mAbs) or even effective drugs available. Human convalescent plasma transfusion is an option for either prophylactic or therapeutic treatment of COVID-19 patients, but its administration to patients who are affected by severe pulmonary disease is associated with increased risk of transfusion-related acute lung injury (TRALI).

medicine.medical_specialtyLymphocyte TransfusionHematologymedicine.drug_classbusiness.industryvirusesmedicine.medical_treatmentHematologyImmunotherapyLung injuryMonoclonal antibodyVirus03 medical and health sciences0302 clinical medicineHLA-E030220 oncology & carcinogenesisInternal medicineImmunologymedicinebusinessCD8030215 immunologyBritish Journal of Haematology
researchProduct

Update in minimally invasive periorbital rejuvenation with a focus on platelet-rich plasma: A narrative review.

2020

Background The periorbital region is among the first areas to be affected by the process of aging, which is influenced by genetic and constitutional factors. As the region plays an important role in overall facial appearance, rejuvenation of the area has immense cosmetic benefit and various treatment modalities have been used to achieve the same. Aims This article reviews commonly used non-surgical and minimally invasive modalities for periorbital rejuvenation. Methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles.…

medicine.medical_specialtyMEDLINEDermatologyCosmetic TechniquesPeriorbital rejuvenation030207 dermatology & venereal diseases03 medical and health sciencesBlood Transfusion Autologous0302 clinical medicineMedicineHumansRejuvenationRejuvenationModalitiesModality (human–computer interaction)business.industryPlatelet-Rich PlasmaDermatologySkin AgingClinical trialTreatment Outcome030220 oncology & carcinogenesisPlatelet-rich plasmaFaceNarrative reviewbusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Base Excess and Lactate Concentration in Infusion Solutions and Blood Products

2002

medicine.medical_specialtyMetabolic alkalosisBlood Component TransfusionAcid–base homeostasisCritical Care and Intensive Care MedicineBlood productInternal medicinemedicineHumansInfusions ParenteralInfusions IntravenousAcidosisChemistryMetabolic disorderGeneral MedicineHydrogen-Ion ConcentrationWater-Electrolyte Balancemedicine.diseaseDilutionSurgeryAnesthesiology and Pain MedicineEndocrinologyHematocritLiverLactatesEmergency MedicineAcidosis LacticBase excessmedicine.symptomPerfusionains · Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct